Acute toxoplasmosis in nonstem cell transplant patients with haematological malignancies: A study from a regional cancer institute in South India

Hematological Oncology

Volumn 26, Issue 4, 2008, Pages 229-233

  Adurthi, S ^a   Sahoo, T P ^a   Chakka, Kumar ^a   Radhika, B ^a   Appaji, L ^a   Bapsy, P P ^a   Ramesh, C ^a   Jayshree, R S ^a  

^a KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY   (India)

Author keywords

B1 gene; Extracerebral toxoplasmosis; Infections in febrile neutropenia; NPCR; Toxoplasma gondii

Indexed keywords

COTRIMOXAZOLE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PREDNISOLONE; PROTOZOAL DNA;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CANCER CENTER; CHILD; CONCURRENT INFECTION; CONTROLLED STUDY; FEBRILE NEUTROPENIA; FEMALE; GENE AMPLIFICATION; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INDIA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TOXOPLASMA GONDII; TOXOPLASMOSIS; BLOOD DISEASE; FEVER; PROSPECTIVE STUDY; SEROLOGY;

ADULT; CHILD; DNA, PROTOZOAN; FEMALE; FEVER; HEMATOLOGIC NEOPLASMS; HUMANS; INDIA; MALE; PROSPECTIVE STUDIES; SEROLOGIC TESTS; STEM CELL TRANSPLANTATION; TOXOPLASMOSIS;

EID: 58949099954     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.864     Document Type: Article

References (32)

1. Catterall JR, Hofflin JM, Remington JS. Pulmonary toxoplasmosis. Am Rev Respir Dis 1986; 133: 704-705.
2. Tschirhart D, Klatt EC. Disseminated toxoplasmosis in the acquired immunodeficiency syndrome. Arch Pathol Lab Med 1988; 112: 1237-1241.
3. Buhr M, HeiseW, Arasteh K, Stratmann M, Grosse M, L'Age M. Disseminated toxoplasmosis with sepsis in AIDS. Clin Invest 1992; 70: 1079-1081.
4. Oksenhendler E, Cadranel J, Sarfati C, Katlama C, Datry A, Marche C, et al. Toxoplasma gondii pneumonia in patients with the acquired immunodeficiency syndrome. Am J Med 1990; 88: 18-21.
5. Slavin MA, Meyers JD, Remington JS, Hackman RC. Toxoplasma gondii infection in marrow transplant recipients: a 20-year experience. Bone Marrow Transplant 1994; 13: 549-557.
6. Derouin F, Devergie A, Auber P, Gluckman E, Beauvais B, Garin YJ, et al. Toxoplasmosis in bone marrow transplant recipients: report of seven cases and review. Clin Infect Dis 1992; 15: 267-270.
7. Chandrasekar PH, Momin F. Disseminated toxoplasmosis in marrow recipients: a report of three cases and a review of the literature. Bone Marrow Transplant 1997; 19: 685-689.
8. Pagano L, Trape G, Putzulu R, Caramatti C, Picardi M, Nosari A, et al. Toxoplasma gondii infection in patients with haematological malignancies. Ann Hematol 2004; 83: 592-595.
9. de Medeiros BC, de Medeiros CR,Werner B, Loddo G, Pasquini R, Bleggi-Torres LF. Disseminated toxoplasmosis after bone marrow transplantation: report of 9 cases. Transpl Infect Dis 2001; 3: 24-28.
10. Martino R, Maertens J, Bretagne S, Rovira M, Deconinck E, Ullmann AJ, et al. Toxoplasmosis after hematopoietic stem cell transplantation. Clin Infect Dis 2000; 31: 1188-1195.
11. Martino R, Bretagne S, Rovira M, Ullmann AJ, Maertens J, Held T, et al. Toxoplasmosis after hematopoietic stem transplantation: report of a 5-year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2000; 25: 1111-1114.
12. Mele A, Paterson PJ, Prentice HG, Leoni P, Kibbler CC. Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplant 2002; 29: 691-698.
13. Roemer E, Blau IW, Basara N, Kiehl MG, Bischoff M, Günzelmann S, et al. Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience. Clin Infect Dis 2001; 32: E1-E8.
14. Small TN, Leung L, Stiles J, Kiehn TE, Malak SA, O'Reilly RJ, et al. Disseminated toxoplasmosis following T cell-depleted related and unrelated bone marrow transplantation. Bone Marrow Transplant 2000; 25: 969-973.
15. Martino R. Toxoplasmosis after hematopoietic stem cell transplantation. In Transplant Infections, Bowden RA, Ljungman P, Paya CV (eds). Lippincott, Williams & Wilkins: Philadelphia, 2003; 535-540.
16. Sundar P, Mahadevan A, Jayshree RS, Subbakrishna DK, Shankar SK. Toxoplasma seroprevalence in healthy voluntary blood donors from urban Karnataka. Indian J Med Res 2007; 26: 50-55.
17. Khalifa KES, Roth A, Roth B, Arasteh KN, Janitschke K. Value of PCR for evaluating occurrence of parasitemia in immunocompromised patients with cerebral and extracerebral toxoplasmosis. J Clin Microbiol 1994; 32: 2813-2819.
18. Guy EC, Joynson DHM. Potential of the polymerase chain reaction in the diagnosis of active Toxoplasma infection by detection of parasite in blood. J Infect Dis 1995; 172: 319-322.
19. Yazar S, Yaman O, Eser B, Alluntas F, Kurnaz F, Sahin I. Investigation of anti-Toxoplasma gondii antibodies in patients with neoplasia. J Med Microbiol 2004; 53: 1183-1186.
20. Hakes TB, Armstrong D. Toxoplasmosis: problems in diagnosis and treatment. Cancer 1983; 52: 1535-1540.
21. Martino R, Bretagne S, Einsele H, Maertens J, Ullmann AJ, Parody R, et al. Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation Clin Infect Dis 2005; 40: 67-78.
22. Bretagne S, Costa JM, Vidaud M, Tran J, Nhieu V, Fleury-Feith J. Detection of Toxoplasma gondii by competitive DNA amplification of bronchoalveolar lavage samples. J Infect Dis 1993; 168: 1585-1588.
23. Paul M. Immunoglobulin G avidity in diagnosis of toxoplasmic lymphadenopathy and ocular toxoplasmosis. Clin Diagn Lab Immunol 1999; 6: 514-518.
24. Figueroa Damian R. Risk of transmission of infectious diseases by transfusion. Ginecol Obstet Mex 1998; 66: 277-283.
25. Galvan Ramirez, ML, Covarrubias X, Rodriguez R, Troyo R, Alfaro N, Correa D. Toxoplasma gondii antibodies in Mexican blood donors. Transfusion 2005; 45: 281-282.
26. Bretagne S, Costa JM, Kuentz M, Simon D, Vidaud M, Fortel I, et al. Late toxoplasmosis evidenced by PCR in a marrow transplant recipient. Bone Marrow Transplant 1995; 15: 809-811.
27. Lewis JS, Jr., Khoury H, Storch GA, DiPersio J. PCR for the diagnosis of toxoplasmosis after hematopoietic stem cell transplantation. Expert Rev Mol Diagn 2002; 2: 616-624.
28. Matsuo Y, Takeishi S, Miyamoto T, Nonami A, Kikushige Y, Kunisaki Y, et al. Toxoplasmosis encephalitis following severe graft-vs.-host disease after allogeneic hematopoietic stem cell transplantation: 17 yr experience in Fukuoka BMT group. Eur J Haematol 2007; 79: 317-321.
29. Sing A, Leitritz L, Roggenkamp A, Kolb HJ, Szabados A, Fingerle V, et al. Pulmonary toxoplasmosis in bone marrow transplant recipients: report of two cases and review. Clin Infect Dis 1999; 29: 429-433.
30. Carr A, Tindall B, Brew BJ, Marriott DJ, Harkness JL, Penny R, et al. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med 1992; 117: 106-111.
31. Caumes E, Lheriteau F, Gentilini M. Cotrimoxazole prophylaxis for toxoplasmosis. Ann Intern Med 1993; 118: 395.
32. Aspinall TV, Joynson DHM, Guy E, Hyde JE, Sims PFG. The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis. J Infect Dis 2002; 185: 1637-1643.